Skip to content
Investment Visual
/
Backtest
Tools
Browse
Stocks
REGN
Financials
Revenue by product
REGN
Regeneron Pharmaceuticals, Inc.
Backtest
REGN
Overview
Returns
Financials
Holders
Insiders
Summary
Statements
Income
Revenue
Revenue by product
Revenue by region
Gross profit
Operating income
Net income
EPS
EBITDA
Cash flow
Balance sheet
Valuation
Shares and dividends
Costs
Revenue by product
Annual
Quarterly
Revenue by product
Annual
Quarterly
2025, ended Dec 31, 2025
Collaboration revenue
$7.3B
51%
Eylea
$2.7B
19%
Elyea HD
$1.6B
11%
Libtayo
$1.5B
10%
Praluent
$263M
2%
Evkeeza
$162M
1%
All other
$750M
5%
Earlier:
Regen-cov
to 2021
Products by fiscal year
CSV
Products by fiscal year
USD
Line, in USD
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Collaboration revenue
7.33B
6.06B
5.50B
4.91B
3.67B
1.19B
—
—
—
—
Net product sales
6.3B
7.6B
7.1B
6.9B
12.1B
5.6B
4.8B
—
—
—
Libtayo
1.45B
1.22B
0.86B
0.45B
0.31B
0.27B
0.18B
15M
—
—
Praluent
263M
242M
182M
130M
170M
151M
—
—
—
—
Evkeeza
162M
126M
77M
49M
18M
—
—
—
—
—
Other products
10M
—
—
—
—
—
—
—
—
—
ELYEA HD And EYLEA
4.38B
5.97B
5.89B
—
—
—
—
—
—
—
Inmazeb
37M
77M
70M
3.0M
—
—
—
—
—
—
Regen-cov
—
—
—
—
5.83B
0.19B
—
—
—
—
Arcalyst
—
—
—
—
2.2M
13M
15M
15M
17M
15M
Eylea
2.75B
4.77B
5.72B
6.26B
5.79B
4.95B
4.64B
4.08B
3.70B
3.32B
Other revenue
703M
515M
536M
365M
281M
557M
174M
—
—
—
Earlier (2)
—
—
—
—
—
1.19B
1.55B
1.04B
2.15B
1.52B
Sanofi collaboration revenue
—
—
—
—
—
1.19B
—
—
—
—
Other
—
—
—
—
—
—
1.55B
1.04B
2.15B
1.52B
Total
14.3B
14.2B
13.1B
12.2B
16.1B
8.5B
6.6B
5.1B
5.9B
4.9B
More Regeneron Pharmaceuticals financials
Revenue
Revenue by region
Gross profit
Operating income
Net income
EPS
Revenue at other companies
ILMN
Illumina, Inc.
NTRA
Natera, Inc.
ELV
Elevance Health, Inc.
HUM
Humana Inc.
HCA
HCA Healthcare, Inc.
AZN
AstraZeneca PLC
Tools
Return calculator